Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (2) , 115-121
- https://doi.org/10.1111/j.1469-0691.2004.01043.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2003
- Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patientsCritical Care, 2003
- Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAPClinical Infectious Diseases, 2003
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002
- The clinical use of colistin in patients with cystic fibrosisCurrent Opinion in Pulmonary Medicine, 2001
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- Inadequate Antimicrobial Treatment of InfectionsChest, 1999
- Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosisThorax, 1997
- A reassessment of the in-vitro activity of colistin sulphomethate sodiumJournal of Antimicrobial Chemotherapy, 1997
- Polymyxin B, Colistin, and Sodium ColistimethateMedical Clinics of North America, 1982